Hepatic preneoplasia in hepatitis B virus transgenic mice
Iljia Toshkov
Abteilung für Cytopathologie, Deutsches Krebsforschungszentrum, D-69120 Heidelberg, Germany
Guest research fellow of the German Cancer Research Center and the Humboldt Foundation.
Search for more papers by this authorFrancis V. Chisari
Division of Experimental Pathology, Scripps Research Institute, La Jolla, California 92037
Search for more papers by this authorCorresponding Author
Professor Dr. Peter Bannasch
Abteilung für Cytopathologie, Deutsches Krebsforschungszentrum, D-69120 Heidelberg, Germany
Abteilung für Cytopathologie (0310), Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany===Search for more papers by this authorIljia Toshkov
Abteilung für Cytopathologie, Deutsches Krebsforschungszentrum, D-69120 Heidelberg, Germany
Guest research fellow of the German Cancer Research Center and the Humboldt Foundation.
Search for more papers by this authorFrancis V. Chisari
Division of Experimental Pathology, Scripps Research Institute, La Jolla, California 92037
Search for more papers by this authorCorresponding Author
Professor Dr. Peter Bannasch
Abteilung für Cytopathologie, Deutsches Krebsforschungszentrum, D-69120 Heidelberg, Germany
Abteilung für Cytopathologie (0310), Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany===Search for more papers by this authorAbstract
Hepatocarcinogenesis in hepatitis B virus transgenic mice was studied by means of a correlative cytomorphological and cytochemical approach at different time points in animals from 1 to 34 mo old. HBsAg-positive ground-glass hepatocytes emerged throughout the liver parenchyma in nearly all transgenic mice during the first 4 mo after birth. The panlobular expression of HBsAg persisted until foci of altered hepatocytes appeared (6 to 9 mo of age). Three different types of foci of altered hepatocytes–namely, glycogen-storage foci, mixed cell foci and glycogen-poor foci–developed. Hepatocellular adenomas and carcinomas appeared after 11 mo. Orcein staining revealed frequent transitions between ground-glass hepatocytes extensively expressing HBsAg and glycogen-storage (predominantly clear-cell) foci containing HBsAg-positive cytoplasmic components. Similar transitions between ground-glass hepatocytes and glycogenotic (clear) cells were often found in diffuse parenchymal glycogenosis at 11 or 12 mo. Remnants of HBsAg-positive material were also detected in mixed cell foci, glycogen-poor diffusely basophilic cell foci, hepatic adenoma and hepatocellular carcinoma. These findings suggest that ground-glass hepatocytes are the direct precursor of foci of altered hepatocytes and their neoplastic descendants. The extensive expression of HBsAg is gradually down-regulated during neoplastic transformation, just as the morphological the biochemical phenotypes of foci of altered hepatocytes, hepatic adenoma and hepatocellular carcinoma in transgenic mice resemble those described in chemical heterocarcinogenesis. The predominant sequence of cellular changes leading from glycogen-storage (predominantly clear cell) foci to mixed cell foci, hepatic adenoma and hepatocellular carcinoma is characterized by a gradual decrease in the activities of glycogen synthase, phosphorylase, glucose-6-phosphatase and adenylate cyclase, whereas glucose-6-phosphate dehydrogenase and pyruvate kinase activities increase. These alterations indicate a shift from the glycogenotic state toward an increase in the pentose phosphate pathway and glycolysis. (Hepatology 1994;20:1162–1172).
References
- 1 Beasley RP, Lin C-C, Hwang LY, Chen C-S. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,207 men in Taiwan. Lancet 1981; 2: 1129–1133.
- 2 Bosch FX, Munoz H. Epidemiology of hepatocellular carcinoma. In: P Bannasch, D Keppler, G Weber, eds. Liver cell carcinoma. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1988: 3–14.
- 3 Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985; 317: 489–495.
- 4 Ganem D, Varmus H. The molecular biology of the hepatitis B virus. Annu Rev Biochem 1987; 56: 651–693.
- 5 Chisari FV, Ferrari C, Mondelli LU. Hepatitis B virus structure and biology. Microbiol Pathogenesis 1989; 6: 311–325.
- 6 Mason WS, Taylor JM. Experimental systems for the study of hepadnavirus and hepatitis delta virus infections. Hepatology 1989; 9: 635–645.
- 7 Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59: 1145–1156.
- 8 Kim C-M, Koike K, Saito J, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317–320.
- 9 Chisari FV, Filippi P, Buras J, McLachlan A, Popper H. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci U S A 1987; 84: 6909–6913.
- 10 Dunsford HA, Sell S, Chisari FV. Hepatocarcinogenesis due to chronic cell injury in hepatitis B virus transgenic mice. Cancer Res 1990; 50: 3400–3407.
- 11 Pasquinelli C, Bhavani K, Chisari FV. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Res 1992; 52: 2823–2829.
- 12 Teeter LD, Becker FF, Chisari FV, Li D, Kuo MT. Overexpression of the multidrug resistance gene mdr 3 in spontaneous and chemically induced mouse hepatocellular carcinomas. Mol Cell Biol 1990; 10: 5728–5735.
- 13 Schirmacher P, Held WA, Yang D, Chisari FV, Rustum Y, Rogler CE. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res 1992; 52: 2549–2556.
- 14 Sell S, Hunt JM, Dunsford HA, Chisari FV. Synergy between hepatitis B virus expression and chemical hepatocarcinogenesis in transgenic mice. Cancer Res 1991; 51: 1278–1285.
- 15 Dragani TA, Manenti G, Farza H, Della Porta G, Tiollais P, Pourcel C. Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesis. Carcinogenesis 1989; 11: 953–956.
- 16 Bannasch P. Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis 1986; 7: 689–695.
- 17 Farber E, Sarma DSR. Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest 1987; 56: 4–22.
- 18 Pitot HC. Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu Rev Pharmacol Toxicol 1990; 30: 465–500.
- 19 Bannasch P, Zerban H. Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response. In: H Vainio, PN Magee, DB McGregor, AJ McMichael, eds. Mechanisms of carcinogenesis in risk identification. Lyon: International Agency for Research on Cancer, 1992: 389–427.
- 20 Chisari FV, Pinkert CA, Milich DR, Filippi P, McLachlan A, Palmiter RD, Brinster RL. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 1985; 230: 1157–1160.
- 21 Shikata T, Uzawa T, Yoshiwara N, Akatsuka T, Yamazaki S. Staining methods of Australian antigen in paraffin section: detection of cytoplasmic inclusion bodies. Jpn J Exp Med 1974; 44: 25–36.
- 22 Hacker HJ, Grobholz R, Klimek F. Enzyme histochemistry and biochemical microanalysis of preneoplastic lesions. Progr Histochem Cytochem 1991; 23: 61–72.
- 23 Hacker HJ. Histochemical demonstration of glycogen phosphorylase (EC 2.4.1.1) through the use of semipermeable membranes. Histochemistry 1978; 58: 289–296.
- 24 Mayer D, Hacker HJ, Bannasch P. Reevaluation of the specificity of adenyl(β,γ-methylene)diphosphonate as a substrate for adenylate cyclase. Histochem J 1991; 23: 100–106.
- 25 Benner U, Hacker HJ, Bannasch P. Electromicroscopical demonstration of glucose-6-phosphatase in native cryostat sections fixed with glutaraldehyde through semipermeable membranes. Histochemistry 1979; 65: 41–47.
- 26 Meijer AEFH, de Vries GT. Semipermeable membranes for improving the histochemical demonstration of enzyme activities in tissue sections. IV. Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase (decarboxylating). Histochemistry 1974; 40: 349–359.
- 27 Henderson B. Quantitative cytochemical measurement of glyceraldehyde-3-phosphate dehydrogenase activity. Histochemistry 1976; 48: 191–204.
- 28 Klimek F, Moore MA, Schneider E, Bannasch P. Histochemical and microbiochemical demonstration of reduced pyruvate kinase activity in thioacetamide induced neoplastic nodules of rat liver. Histochemistry 1988; 90: 37–42.
- 29
Z Lojda,
R Gossrau,
TH Schiebler, eds.
Enzyme histochemistry.
Berlin:
Springer,
1979.
10.1007/978-3-642-67234-7 Google Scholar
- 30 Sato K, Kitahara A, Satoh K, Ishikawa T, Tatematsu M, Ito N. The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical carcinogenesis. Gann 1984; 75: 199–202.
- 31 Hacker HJ, Mtiro H, Bannasch P, Vesselinovitch SD. Histochemical profile of mouse hepatocellular adenomas and carcinomas induced by single dose of diethylnitrosamine. Cancer Res 1991; 51: 1952–1958.
- 32 Wu PC, Lam KC. Cytoplasmic hepatitis B surface antigen and the ground glass appearance in hepatocellular carcinoma. Am J Clin Pathol 1979; 71: 229–234.
- 33 Nazarewicz T, Krawczynski K, Slusarczyk J, Nowoslawski A. Cellular localization of hepatitis B virus antigens in patients with hepatocellular carcinoma coexisting with liver cirrhosis. J Infect Dis 1977; 135: 298–302.
- 34 Bannasch P, Mayer D, Hacker HJ. Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim Biophys Acta 1980; 605: 217–245.
- 35 Moore MA, Mayer D, Bannasch P. The dose dependence and sequential appearance of putative preneoplastic populations induced in rat liver by stop experiments with N-nitrosomorpholine. Carcinogenesis 1982; 3: 1429–1436.
- 36 Enzmann H, Bannasch P. Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis. Carcinogenesis 1987; 8: 1607–1612.
- 37 Bannasch P, Enzmann H, Klimek F, Weber E, Zerban H. Significance of sequential cellular changes inside and outside foci of altered hepatocytes during hepatocarcinogenesis. Toxicol Pathol 1989; 17: 617–629.
- 38 Steinberg P, Hacker HJ, Dienes HP, Oesch F, Bannasch P. Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethione supplemented diet. Carcinogenesis 1991; 12: 225–231.
- 39 Enzmann H, Zerban H, Löser E, Bannasch P. Glycogen phosphorylase hyperactive foci of altered hepatocytes in aged rats. Virchows Arch B Cell Pathol 1992; 62: 3–8.
- 40 Hacker HJ, Steinberg P, Toshkov I, Oesch F, Bannasch P. Persistence of cholangiocellular and hepatocellular lesions observed in rats fed a choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis 1992; 13: 271–276.
- 41 Klimek F, Bannasch P. Biochemical microanalysis of α-glucosidase activity in preneoplastic and neoplastic hepatic lesions induced in rats by N-nitrosomorpholine. Virchows Arch B Cell Pathol 1989; 57: 245–250.
- 42 Grobholz R, Hacker HJ, Thorens B, Bannasch P. Reduction in the expression of glucose transporter protein GLUT2 in preneoplastic and neoplastic lesions and reexpression of GLUT1 in late stages of hepatocarcinogenesis. Cancer Res 1993; 53: 4204–4211.
- 43 Bannasch P, Hacker HJ, Klimek F, Mayer D, Stumpf H, Zerban H. Cytochemical, microbiochemical and molecular genetic analysis of chemical carcinogenesis. Progr Histochem Cytochem 1991; 23: 45–60.
- 44 Weber G. Enzymology of cancer cells, part 1 and 2. N Engl J Med 1977; 296: 486–493, 541–551.
- 45
Bannasch P,
Jahn U-R,
Zerban H.
Preneoplastic lesions as early indicators of neoplastic development.
In: P Bannasch, ed.
Cancer diagnosis: early detection.
Berlin:
Springer,
1992:
178–190.
10.1007/978-3-642-76899-6_21 Google Scholar
- 46 Bannasch P. Phenotypic cellular changes as indicators of stages during neoplastic development. In: OH Iversen, ed. Theories of carcinogenesis. Washington, D.C.: Hemisphere, 1988: 231–249.
- 47 Bianchi L. Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr 1993; 152: S63–S70.
- 48 Woodgett JR. A common denominator linking glycogen metabolism, nuclear oncogenes, and development. Trends Biochem Sci 1991; 16: 177–181.
- 49 Plyte SE, Hughes K, Nikolakaki E, Pulverer B, Woodgett JR. Glycogen kinase-3: functions in oncogenesis and development. Biochim Biophys Acta 1992; 1114: 147–162.